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In vivo targeted therapy of gastric tumors via the
mechanical rotation of a flower-like Fe3O4@Au
nanoprobe under an alternating magnetic field
Ting Yin1, Haigang Wu2, Qian Zhang1, Guo Gao1, Joseph G Shapter3, Yulan Shen4, Qiaozhi He1,
Peng Huang1, Wen Qi1, Chunlei Zhang1, Yuming Yang1 and Daxiang Cui1
Owing to their hypotoxicity, great spatial resolution and tomographic properties, Fe3O4 nanoparticles (NPs) are becoming one of
the most promising materials for noninvasive biological imaging and shape-dependent therapeutic agents for malignant tumor
therapy. Conventional spherical NPs are unable to effectively destroy cellular structure in therapy and thus result in tumors with
a high risk of drug resistance. Herein we developed a novel flower-like targeting Fe3O4@Au-HPG-Glc nanoprobe (thiol-containing
hyperbranched polyglycerol (HPG); 4-aminophenyl β-D-glucopyranoside (Glc)) that can enhance magnetic resonance imaging
(MRI) for cancer therapy. With the guidance of a targeting molecule, Fe3O4@Au-HPG-Glc nanoprobes can precisely target tumor
cells. Under an alternating magnetic field (AMF), the flower-like Fe3O4@Au-HPG-Glc nanoprobes can rotate along the central
axis of the core to substantially destroy tumor cells by damaging the nucleus or cell membrane. Our results showed that this
shape-dependent therapeutic agent-based strategy had remarkable efficacy for MRI-guided tumor therapy. Furthermore, the
inhibition of tumor growth in tumor-bearing mice was up to approximately 47.3% on the twelfth day of treatment compared with
the level of inhibition in a blank group. Different from other reported methods for cancer therapy, our proposed AMF-dependent
targeted cancer therapy is a novel strategy that can potentially reduce drug resistance in gastric tumors.
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INTRODUCTION
With the development of advanced nanotechnology, the rational
integration of multifunctional nanoplatforms for early diagnoses and
cancer therapies are of great interest.1,2 Among the imaging techni-
ques, magnetic resonance imaging (MRI) is considered one of the
most promising noninvasive clinical tools due to significant merits,
such as excellent spatial resolution and sensitivity, and especially for
providing excellent three-dimensional and tomographic contrast
information of soft tissue.3,4 The inherent characteristics of pure
Fe3O4 nanoparticles (NPs; for example, poor colloidal stability and
low targeted retention at the tumor site) have hindered their wide
application in nanomedicine. Hence, surface modifications (for
example, organic or inorganic coating) of pure Fe3O4 NPs have
attracted extensive attention.5,6 Fe3O4 NPs with modified surface
layers have been used as carriers to deliver anticarcinogens.7 Despite
great efforts to explore anticancer adjuvants, the issue of drug
resistance in cancer therapy remains a challenging problem. Herein
we developed an oriented growth method for the controllable
synthesis of flower-like Fe3O4@Au NPs. Owing to the axial
dissymmetry of the flower-like Fe3O4@Au NPs, this nanoplatform
freely rotates under an alternating magnetic field (AMF), which can
efficiently destroy tumor cells. The unique properties of flower-like
Fe3O4@Au NPs were superior to that of traditional spherical Fe3O4
magnetic NPs with symmetric structures.8 The special structural
property of flower-like Fe3O4 NPs allowed for the development of a
high-efficiency MRI-guided therapy.
To improve the colloidal stability of Fe3O4@Au NPs, thiol-
containing hyperbranched polyglycerol (HPG) with rich branches
were bonded onto the surface of Fe3O4@Au NPs. The functional
groups on the surfaces of the dendrimers enable the coupling of
targeting ligands and fluorescent probes to be used as drug carriers for
the diagnosis and therapeutic treatment of cancer.9–11 Furthermore,
these functional groups also act as excellent stabilizers or templates in
the preparation of versatile nanoplatforms for biological imaging
applications.12–14 Modified NPs using HPG dendrimers have been
shown to reduce the in vivo adsorption of plasma proteins on the
polymer surfaces of NPs with diameters o100 nm.15 Recently, efforts
have focused on the application of biological targeting molecules (for
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example, antibodies, carbohydrates and peptides) to modify the
surface of nanoplatforms in biological systems.16,17 Glucose is a
carbohydrate and is an important energy source for cell survival and
recognition.18 Owing to high energy demands and metabolism in
malignant cells, the cellular uptake of glucose varies among different
cancer cell types.19 In our previous work, we found that Au
nanoprisms coated with glucose can effectively promote cellular
uptake in gastric cancer for potential in vivo applications in imaging
and therapy.20,21 However, we noticed that traditional spherical
nanoprobes face drug resistance issues in cancer therapy. Destroying
malignant cellular structure has become one of the most effective ways
to reduce drug resistance.
In this study, novel flower-like Fe3O4@Au-HPG-Glc nanoprobes
were developed. One of the glucose derivatives, namely,
4-aminophenyl β-D-glucopyranoside (Glc), was used as the targeting
molecule. These nanoprobes were designed to destroy malignant
cellular structure by mechanically rotating the nanoprobes around
the central axis of the core under an AMF. With the guidance of a
targeting Glc molecule, the synthesized Fe3O4@Au-HPG-Glc nanop-
robes precisely targeted tumor cells for MRI-guided therapy. Nega-
tively charged gold clusters were loaded onto the surfaces of positively
charged Fe3O4 NPs using electrostatic interactions and surface effects.
The Fe3O4@Au NPs were modified with thiolated HPG dendrimers
(SH-HPG) through S-Au bonds. HPG dendrimer terminals were
coupled with Glc via acetylation. The synthesized flower-like
Fe3O4@Au-HPG-Glc nanoprobes were applied as a T2 contrast agent
to trace the variations in tumors before and after treatment based on
prolonged retention time and enhanced cellular uptake in the targeted
region (Figure 1). The flower-like Fe3O4@Au-HPG-Glc nanoprobes
were successfully applied in imaging-guided targeting cancer therapy
under an AMF. The AMF-dependent therapy strategy can destroy the
tumor cellular structure and reduce drug resistance.
EXPERIMENTAL PROCEDURES
Materials
Ethylene glycol, diethylene glycol, polyvinylpyrrolidone K30 (PVP), ferric
chloride hexahydrate (FeCl3·6H2O), sodium acetate trihydrate, ethanol,
tetrahydrofuran, acetic acid, formaldehyde, hydrogen tetrachloroaurate (III)
hydrate (HAuCl4·4H2O), sodium borate (Na2B4O7·10H2O), NaH (60% in
mineral oil), bis(2-hydroxyethyl)disulfide and a dioxane solution of glycidol
were purchased from the Sinopharm Chemical Reagent Co., Ltd. (Shanghai,
China). Glutathione, Glc, N-hydroxysulfosuccinimide, 3-hydroxytyramine
hydrochloride, 3-[4,5-dimethylthiazol-2-yl]-2 and 5-diphenyltetrazolium bro-
mide (MTT), 1-ethyl-3-[3-dimethylaminopropyl] carbodiimide hydrochloride
were obtained from Sigma-Aldrich Chemical Co., Ltd. (St Louis, MO, USA).
MGC-803 cells were obtained from the Chinese Academy of Sciences, Beijing,
China. All cell culture media were provided by GIBCO (Shanghai, China).
Water was purified on a Milli-Q water system (Millipore Co., Bedford, MA,
USA) with a resistivity of 18.2 MΩ at each step.
Preparation of flower-like Fe3O4@Au-HPG-Glc NPs
Synthesis of flower-like superparamagnetic Fe3O4 NPs. In a typical procedure,
FeCl3·6H2O (8 mmol) was dissolved in a mixture of ethylene glycol and
diethylene glycol (volume ratio of 3:17) under ultrasonic conditions at room
temperature. After half an hour, 8 g of PVP was poured into the yellow
transparent mixture under a nitrogen atmosphere and heated for 1 h at 125 °C.
After the PVP surfactant was completely dissolved, NaOAc (6 g) was added,
and the stirring speed was increased. After 0.5 h, the mixture was heated to
200 °C for 12 h in a 100-ml Teflon-lined stainless-steel autoclave. After
reacting, Fe3O4 NPs were collected by magnetic separation and washed with
ultrapure water (UPW) and ethanol three times. Then the obtained product
was redispersed in the same volume of cold tetrahydrofuran. The synthesized
Fe3O4 dispersion solution was stored in a freezer at 4 °C until required.
Synthesis of flower-like superparamagnetic Fe3O4@Au NPs
Dopamine (DA) modification. Briefly, 20 mg of DA was dissolved in 1.5 ml
UPW and added to a 5 ml Fe3O4 NP dispersion, which was sonicated for 1 h.
The mixture was left on the shaking table overnight. The obtained Fe3O4-DA
was purified via magnetic separation and well dispersed in 20 ml of UPW by
ultrasound.
Gold seed. Red-emitting gold nanoclusters were used as gold seeds and
prepared using previously reported procedures.22 In a typical synthesis, HAuCl4
(50 μmol) and glutathione (150 μmol) were mixed in a 100-ml round bottom
flask with 50 ml of UPW. After reacting for 3 min, 3 ml of tetrabutylammo-
nium bromide solution was poured into the mixture, and the solution was
reacted for 5 min. The mixture was kept in an ice bath for 2 h, and 1 M HCl
was added dropwise to adjust the pH to 3.0. Subsequently, the reaction solution
Figure 1 Schematic of flower-like Fe3O4@Au-HPG-Glc nanoprobes for in vitro/vivo MRI and therapy of gastric tumors under an alternating magnetic field.
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was left to stand in an ice bath overnight. Negatively charged colloidal gold
seeds were obtained.
Growth solution. HAuCl4 (1.5 ml, 25 mM) was mixed into a 0.18 M potassium
carbonate solution. After stirring for 10 min, the faint yellow solution turned
colorless. After another 24 h, the growth solution was formed and stored in a
fridge at 4 °C for future experiments.
Fe3O4@Au NPs. First, the negatively charged red-emitting gold nanoclusters
were attached to the surface of the DA-modified Fe3O4 NPs through
electrostatic interactions. The red-emitting gold nanoclusters (200 μl,
12 mg ml− 1) were added to 2 ml of Fe3O4-DA. Subsequently, 5 ml of UPW
was quickly added, and the mixture was shaken for 5 min. Then 0.2 M acetic
acid solution was added dropwise into the mixture to adjust the pH to ~4.0.
The reaction solution was shaken for 12 h and purified using magnetic
separation three times. The collected Fe3O4@Au seed NPs were dissolved in
5 ml of UPW. Subsequently, a dense gold shell on the surface of Fe3O4 NPs was
formed by a seed-induced growth method. Then 10 ml of this gold growth
solution was poured into the Fe3O4@Au seed-dispersing agent (5 ml) under
vigorous shaking. Formaldehyde solution (6 ml, volume ratio of formaldehyde
to UPW of 1:1), acting as a reducing agent, was added to the reaction mixture
dropwise. Then the mixture was vigorously shaken for another 30 min. Thus
the gold NPs were loaded onto the Fe3O4 NPs via a seed-mediated growth
method.
Synthesis of SH-HPG-COOH dendrimers. NaH (0.01 mol, 60% in mineral oil)
was added to a dioxane solution (10 ml) containing bis(2-hydroxyethyl)
disulfide (120 μl) and mixed at 95 °C for 15 min. Then 4.2 ml of glycidol in
10 ml of dioxane was mixed dropwise under an argon atmosphere and stirred
at 95 °C for 12 h.23 After this reaction, the organic phase was removed, and the
solid precipitate was dissolved in 10 ml of UPW. The polyglycerol solution was
purified for 24 h by dialysis (molecular weight cutoff 3 K) and dried in a FD-2A
vacuum freeze dryer (Biocool Experimental Equipment Co., Ltd, Beijing,
China). The obtained disulfide-containing hyperbranched polyglycerol (HPG-
S-S-HPG) (164 mg) was dissolved in 10 ml of UPW under an argon atmo-
sphere. Then dithiothreitol (400 μl, 0.5 M) was added to the reaction mixture
and reacted at 50 °C for 24 h. The yellow products were purified for 24 h by
dialysis (molecular weight cutoff 3 K) and dried in a vacuum freeze dryer.
Synthesis of flower-like superparamagnetic Fe3O4@Au-HPG-Glc nanoprobes.
The Fe3O4@Au NPs modified by HPG were modified with Glc to accelerate
cellular uptake. In brief, 6 mg of HPG were added to a Fe3O4@Au NP solution
(1 ml, 4 mg ml− 1) using ultrasound for 3 h. The obtained Fe3O4@Au-HPG was
activated using 1.5 mg ml− 1 N-hydroxysulfosuccinimide and 1-ethyl-3-[3-
dimethylaminopropyl] carbodiimide hydrochloride in SBB 9 buffer (50 mM
boric acid solution was adjusted to pH 9 using 0.4 M NaOH) for 30 min. The
activated Fe3O4@Au-HPG NPs were collected by magnetic separation and
subsequently reacted with Glc (1 mg) overnight at room temperature on a
rotational mixer. The products were purified by magnetic separation. The
concentration of Fe3O4@Au-HPG-Glc nanoprobes was determined by induc-
tively coupled plasma (ICP)–atomic emission spectrometry.
Characterization
The morphologies of the Fe3O4 and Fe3O4@Au NPs were observed using
transmission electron microscope (TEM) and high-resolution TEM (HRTEM)
with a JEM-2100F instrument (JEOL, Tokyo, Japan). The ultraviolet (UV)–
visible absorption spectra of Fe3O4@Au, Fe3O4@Au-HPG, Glc and Fe3O4@Au-
HPG-Glc were measured using a Varian Cary 50 spectrophotometer (Varian
Inc., Palo Alto, CA, USA). The Fourier transform infrared (FTIR) spectra of
Fe3O4@Au, Fe3O4@Au-HPG and Fe3O4@Au-HPG-Glc were captured by a
Nicolet 6700 spectrometer using KBr-supported pellets (Thermo Scientific,
Waltham, MA, USA). Dynamic light scattering was measured with a NICOMP
380 ZLS ζ potential/particle sizer (PSS Nicomp, Santa Barbara, FL, USA). The
magnetization loops of Fe3O4 and Fe3O4@Au-HPG-Glc were determined on an
Ever Cool-II physical property measurement system with 9 Tesla magnets
(Quantum Design, San Diego, CA, USA). The T2 relaxation times of different
concentrations of samples were obtained with a 1.4 T Bruker Minispec analyzer
(nuclear magnetic resonance (NMR), MQ60, Karlsruhe, Germany). The
various concentrations of nanoprobes (diluted with UPW) were shifted in
sample tubes and remained constant, immersed in a 37 °C circulating water
bath. The T2 values corresponding to serial concentration (mM) plots for
Fe3O4@Au-HPG-Glc NPs were obtained. The r2 values (mM
− 1 s− 1) were
obtained from the slopes of the optimum fits. MGC-803 cells were photo-
graphed with a microscope (NIKON TS100-F, Tokyo, Japan).
Cytotoxicity assay
The MGC-803 cells were incubated in 75-cm2 cell culture flasks at 37 °C and
5% CO2 and immersed in 20 ml of Dulbecco’s Modified Eagle’s Medium with
penicillin (500 μl, 100 U ml− 1) and 10% (vol/vol) heat-inactivated fetal bovine
serum. Then the toxicity of different concentrations of Fe3O4@Au-HPG and
Fe3O4@Au-HPG-Glc were investigated using an MTT viability assay of
MGC-803 cells.
Endocytosis of Fe3O4@Au-HPG-Glc NPs
MGC-803 cells (2× 105 cells per well) were seeded in culture dishes overnight
at a certain density and cultured in an incubator at 37 °C with 5% CO2. Then
the culture media were replaced with fresh media containing Fe3O4@Au-HPG-
Glc NPs. After 24 h of culturing, the adherent cells were gently rinsed twice
using phosphate-buffered saline (PBS) to remove noninternalized nanoprobes.
Subsequently, the cells were trypsinized and concentrated into a pellet by
centrifugation at 1300 r.p.m. for 5 min. Then the pelleted nanoprobes were
dispersed in 2.5% glutaraldehyde overnight at 4 °C. Following conventional
protocols, a slice of the cells was fixed on a copper net and stained. The
distribution of synthesized nanoprobes adsorbed into cells was obtained by an
80 kV B-TEM (Tecnai G2 Spirit Biotwin, FEI, Tokyo, Japan). Untreated
MGC-803 cells served as the control group.
In vitro cytoclasis of MGC-803 cells via mechanical rotation of
Fe3O4@Au-HPG-Glc nanoprobes under an AMF
MGC-803 cells were incubated in three 6-cm-diameter culture dishes and
allowed to adhere for 12 h. Subsequently, 5 ml of fresh media with the same
concentrations of Fe3O4@Au-HPG and Fe3O4@Au-HPG-Glc (10 μl,
4 mg ml− 1) were added to each dish. The final concentrations of Fe3O4@Au-
HPG and Fe3O4@Au-HPG-Glc interacting with MGC-803 cells were
8 μg ml− 1. The cells were washed three times using PBS solution to remove
noninternalized targeted/nontargeted nanoprobes after 24 h of incubation.
Simultaneously, fresh medium was added, and the culture dishes were placed
directly on the center of a stirring platform for 5 min at 10-min intervals.
MGC-803 cells were subjected three times to the mechanical rotation of
targeted/nontargeted nanoprobes under an AMF and were monitored by
fluorescence microscopy.
Establishment of the xenografted tumor models
Based on routine protocols advocated by the institutional committee for animal
care and the National Ministry of Health, the animal experiments were carried
out in accordance with the Ethics Committee of Shanghai Jiao Tong University.
A transplanted tumor model of gastric cancer was prepared in the right flank
skin of female nude mice via subcutaneous injection of 1× 106 MGC-803 cells.
After approximately 1 month, the formed solid tumors were harvested and cut
into small fragments with edge lengths of approximately 0.2 cm. Then the
healthy mice were anesthetized. An incision in the back right flank skin was
made, and a small tumor lump was quickly pushed into the incision channel.
Subsequently, the incision was sewn closed. After 4 additional weeks, the
subcutaneously transplanted tumor models of gastric cancer were established.
All surgical steps were completed in a sterile environment.
In vivo MRI
All MR in vivo imaging was carried out before and at fixed time points of 0, 4, 8,
12 and 24 h postinjection using a clinical 3.0 T Siemens Magnetom Trio medical
MR system (Shanghai Sixth People’s Hospital Radiology Department of MRI,
Shanghai, China) with a customized small animal detection coil. The measure-
ment parameters were: time to echo= 52 ms, repetition time= 2600 ms, field of
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view= 1×1 cm2, slice thickness=2 mm, matrix= 320×256, NEX= 2, and
acquisition time= 96 s. When collecting data at set time points, the tumor-
burdened mice were anesthetized and placed in the coil. The corresponding
T2-weighted gray values were detectable with the clinical MRI software.
In vivo biodistribution
Female mice with subcutaneously transplanted tumors were injected with
100 μl of Fe3O4@Au-HPG and Fe3O4@Au-HPG-Glc (the mass ratio of the
nanoprobes to total mouse body weight was 0.5 g kg− 1) via the tail vein. The
mice were killed at 24 h postinjection. Then the main organs and tumors were
harvested, weighed and digested using concentrated nitric acid overnight.
Tumor and tissue fats were decomposed with perchloric acid under heating.
The Fe and Au contents in the tumors and organs were obtained by ICP–
atomic emission spectrometry and ICP–mass spectrometry.
In vivo magnetic therapy via mechanical rotation of Fe3O4@Au-
HPG-Glc NPs under an AMF
To evaluate the therapeutic efficiency of the Fe3O4@Au-HPG-Glc nanoprobes,
MGC-803 tumor-bearing mice were treated with 100 μl of either Fe3O4@Au-
HPG or Fe3O4@Au-HPG-Glc. When the solid tumor volume was approxi-
mately 100 mm3, five experiments (five mice per group) were prepared: (1)
PBS (100 μl) with AMF; (2) Fe3O4@Au-HPG (0.5 g kg− 1 of nanoprobes)
without AMF; (3) Fe3O4@Au-HPG-Glc (0.5 g kg
− 1 of nanoprobes) without
AMF; (4) Fe3O4@Au-HPG (0.5 g kg
− 1 of nanoprobes) with AMF; and (5)
Fe3O4@Au-HPG-Glc (0.5 g kg
− 1 of nanoprobes) with AMF. For the therapy
groups, a large rotating magnet (approximately 400 mT) was placed in the
rearing cage after intratumoral injection to provide the AMF. The relevant
optical images and tumor volume were recorded every 3 days. At day 12, the
mice were killed, and the primary organs (for example, spleen, liver and
kidney) of mice in the blank and experimental groups were collected and fixed
with 4% paraformaldehyde overnight. Subsequently, these harvested tissues
were sliced after paraffin embedding, fixed on a slide and stained using
hematoxylin and eosin according to routine methods. Morphological char-
acteristics and pathological changes were observed by microscopy.
Statistical analysis
All data were processed as the mean± s.d. Statistical significance of the data was
determined using the SPSS 18.0 software (IBM Co., Armonk, NY, USA) and
based on Student’s t-test. Differences of Po0.05 and Po0.01 were considered
significant.
RESULTS AND DISCUSSION
Characterization of SH-HPG-COOH dendrimers
The synthesis of the HPG dendrimer is shown in Supplementary
Figure S1. The structure of the HPG dendrimer was confirmed by the
NMR spectra, including the 1H (Supplementary Figure S2) and 13C
(Supplementary Figure S3) spectra. The 1H NMR spectrum of HPG
showed the characteristic proton signals of the -CH2S- units of HPG at
2.7 p.p.m. Because hydroxyl groups will be used for anchoring
biomolecules, succinic anhydride was used to convert the hydroxyl
groups to carboxyl groups in order to promote bonding with the
targeted molecules. The carboxyl groups in the HPG dendrimer were
observed at 61 p.p.m. in the carbon spectrum (Supplementary
Figure S3). The yellow monothiol-functionalized HPG solution was
obtained by the reduction of disulfide bonds using dithiothreitol.
Based on the 1H NMR spectrum of HPG-S-S-HPG, the number-
average (Mn) molecular weight was approximately 29 900 g mol
− 1
(Supplementary Figure S4). From the FTIR spectrum
(Supplementary Figure S5), a wide absorption band at 3409 cm− 1
can be attributed to the overlapping stretching vibrations of multiple
alcoholic hydroxyl groups.24 The peak at 1248 cm− 1 was due to the
C−O−C stretching vibrations on the HPG chain.25 The characteristic
peak at 1591 cm− 1 confirmed the presence of COOH, which was
consistent with the antisymmetric stretching vibration of carboxyl
groups.26 These results confirmed the formation of SH-HPG-COOH
dendrimers.
Characterization of flower-like Fe3O4@Au and Fe3O4@Au-HPG-Glc
NPs
The flower-like Fe3O4@Au NP structure was characterized by TEM
and HRTEM. The nanoprobe composition was analyzed via energy-
dispersive spectroscopy. Figure 2a shows that the flower-like Fe3O4
NPs (average diameter of approximately 60 nm) were uniform in
shape and monodispersed. Figure 2b shows that the crystal spacing of
the Fe3O4 NP was the same as a (111) lattice spacing (0.485 nm).
27
The clear crystal lattice indicated a highly crystalline nature of the
flower-like Fe3O4 NPs. Figures 2c and d show that the flower-like
Fe3O4 NPs were covered by an Au layer containing numerous
Figure 2 Representative TEM images of (a) Fe3O4 and (c) Fe3O4@Au; HRTEM images of (b) Fe3O4 and (d) Fe3O4@Au. Note that the red circles are labeled
Au NPs on the surface of Fe3O4 NPs.
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ultrasmall high-crystallinity Au NPs. The flower-like Fe3O4@Au
composition was further verified by energy-dispersive spectroscopy
(Supplementary Figure S6), revealing the existence of Au, Fe and O.
To enhance the colloidal stability of the obtained flower-like
Fe3O4@Au NPs, the NPs were modified with HPG polymer, which
contained a sufficient amount of sulfhydryl groups that facilitated the
formation of gold–thiol bonds. The interaction with HPG dendrimers
was confirmed by the UV–vis (Figure 3a) and FTIR spectra
(Figure 3b). Fe3O4@Au-HPG-Glc was easily dispersed at high con-
centrations in various aqueous solutions, including PBS buffer
solution (pH 7.4), cell media, UPW and deionized water
(Supplementary Figure S7b). To improve cellular uptake, Glc was
used as a target molecule and anchored to the surface of the
Fe3O4@Au-HPG NPs. This improved the targeting ability of the
NPs due to the overexpression of membrane Glc transporters in
gastric cancer cells.20 Furthermore, modifications with Glc potentially
enhance the biocompatibility of NPs and reduce their cytotoxicity in
clinical applications.28
The characteristic absorption peak at 280 nm in Figure 3a is
representative of phenyl groups from Glc. Additionally, the peak in
the UV–vis absorption curve of Fe3O4@Au-HPG-Glc also appeared at
approximately 280 nm. This peak has a slight blueshift, and the
absorption band appeared wider when compared with the peaks
arising from pure Glc. These differences were attributed to the
formation of an amide bond between the HPG dendrimer and Glc.
The FTIR spectra of Fe3O4@Au-HPG NPs were also affected by the
presence of Glc. From Figure 3b, four new absorption peaks were
observed at 1044, 1074, 1235 and 1511 cm− 1. The 1511 and
1074 cm− 1 peaks are assigned to the stretching vibrations of C=C
bonds in the aromatic ring and C-OH bonds in Glc,24 respectively.
The peak at 1044 cm− 1 is due to the symmetrical stretching vibration
of C-O-C bonds.25 The peaks approximately 1235 cm− 1 are attributed
to the stretching vibration of the C-N in secondary amides, which
further confirmed successful covalent coupling between the HPG
dendrimer and Glc.29 After the modification by HPG, the Fe3O4@Au
NPs still formed good dispersions due to the formation of gold–thiol
bonds between rich hydroxyl/carboxyl functional groups and Au
clusters (Supplementary Figure S7a). The as-prepared monodisperse
flower-like Fe3O4@Au NPs can be easily dispersed into UPW and
quickly separated by an external magnetic field within seconds. This
excellent colloidal stability can enhance the application of Fe3O4@Au-
HPG-Glc NPs for MRI and targeted therapy under AMFs. The
hydrodynamic sizes of the Fe3O4@Au and Fe3O4@Au-HPG-Glc were
264 and 458 nm, respectively (Supplementary Figure S8), which are
larger than the sizes determined by TEM. This difference was likely
due to the aggregation of NPs in UPW, as reported in previous work.30
To explore the potential applications of flower-like Fe3O4@Au-
HPG-Glc nanoprobes for MRI, magnetization loop and T2 MR
relaxometry measurements were carried out. The magnetization
curves showed the superparamagnetic behavior of Fe3O4 and
Figure 3 (a) UV–vis absorption of Fe3O4@Au (black curve), Fe3O4@Au-HPG (red curve), pure glucose (blue curve) and Fe3O4@Au-HPG-Glc (pink curve);
(b) FTIR spectra of the Fe3O4@Au (black curve), Fe3O4@Au-HPG (red curve) and Fe3O4@Au-HPG-Glc nanoprobes (blue curve). (c) Magnetization loops of the
Fe3O4 and Fe3O4@Au-PG-Glc nanoprobes, measured at 300 K. (d) Linear fitting of 1/T2 for Fe3O4@Au-HPG-Glc with Fe concentrations of 0.016, 0.032,
0.0625, 0.125, 0.25, 0.5 and 1 mM.
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Fe3O4@Au-PG-Glc nanoprobes. The saturation magnetizations were
approximately 80.1 and 47.6 emu g− 1 before and after modification
(Figure 3c), respectively. The saturation magnetization was measured
at 300 K with a field up to 3 T. Figure 3d shows that the r2 relaxivity
was 134.8 mM− 1s− 1, indicating that the synthesized flower-like
Fe3O4@Au-HPG-Glc nanoprobes could be used as a T2 contrast
medium in MRI.31 The cytotoxicity of flower-like Fe3O4@Au-HPG-
Glc nanoprobes was measured via the MTT assay (Supplementary
Figure S9). The cell survival rate was nearly unaffected by increasing
nanoprobe concentrations. This result indicated that the HPG
dendrimer layer on the surface of the Fe3O4@Au-HPG-Glc nanop-
robes could enhance the biological compatibility and colloidal stability
of the NPs to facilitate subsequent in vivo imaging and therapy.
In vitro cytoclasis of MGC-803 cells via mechanical rotation of
Fe3O4@Au-HPG-Glc nanoprobes under an AMF
To evaluate the cellular localization of Fe3O4@Au-HPG-Glc nanop-
robes, ultrastructural features of MGC-803 cells treated with nanop-
robes under an AMF were observed using TEM. Figure 4a shows that,
within observed black patches inside cell cytoplasm, nanoprobes were
detected, which were formed via receptor-mediated endocytosis.
Furthermore, the majority of internalized nanoprobes were located in
lysosomes, suggesting an endocytotic mechanism (Figures 4b and c).
Interestingly, the cytoplasm-distributed nanoprobes were encapsulated
in bilayer membrane vesicles formed by grid proteins. Based on the
TEM images, the majority of flower-like Fe3O4@Au-HPG-Glc nanop-
robes were observed in the lysosomes of MGC-803. The Fe3O4@Au-
HPG-Glc nanoprobes first interacted with receptors in cell membranes
via a receptor-mediated method, leading to the formation of a pit
coated with grid proteins. The vesicles were gradually formed through
the invagination of the pit from the membrane. After the capsule
depolymerization of the vesicles, the vesicles were integrated with
lysosomes. The phagotrophic nanoprobes were hydrolyzed by lysoso-
mal enzymes. Enzymatic hydrolysates remained distributed in the
cytoplasm. Under an AMF, all flower-like nanoprobes distributed in
these sites were rotated, which resulted in the mechanical destruction
of tumor cells via cell membrane damage, organelle damage and cell
disintegration. Via these external magnetic field effects, the partial
flower-like nanoprobes thoroughly damaged cell nuclei, reducing
drug resistance. The special rotating property of the flower-like
Fe3O4@Au-HPG-Glc nanoprobes suggested the feasibility of using
these nanoprobes as ‘nano-turbine blades’ under an AMF.
Figures 5 and 6 show the morphology at different magnifications of
MGC-803 cells after treatment with Fe3O4@Au-HPG-Glc nanoprobes
under an AMF. The cells were stretched (Figure 6a), and pinholes
appeared in the cell membranes (Figure 6b and 6d). Some cells
disintegrated Figure 6c, and the ‘nano-turbine blade’ may have
destroyed the tumor cells with the assistance of an AMF. This
powerful physical therapy will likely reduce the drug resistance
commonly encountered in malignant tumor therapy. Interestingly,
the residual enzymatic hydrolysate distributed in the cytoplasm can
still have a key role in damaging other organelles to provide novel
pathways for tumor treatment.
In vivo MRI
To verify the effectiveness of Fe3O4-based nanoprobes as a T2 contrast
agent, nontargeted Fe3O4@Au-HPG and targeted Fe3O4@Au-HPG-Glc
were intravenously injected into mice for MRI. Compared with the
nontargeted Fe3O4@Au-HPG nanoprobes, the targeted Fe3O4@Au-
HPG-Glc nanoprobes exhibited prolonged retention in the tumor
boundaries due to enhanced cellular endocytosis and accumulation in
the tumor site via binding with corresponding ligands.32 T2-weighted
MR images (Figure 7a) in the tumor site were acquired before
injection and at 0, 4, 8, 12 and 24 h postinjection. Compared with
the MR signal values before injection, the MR signal value of mice
injected with nontargeted Fe3O4@Au-HPG had a decreasing trend up
to 8 h and showed an evident increase after 12 h, indicating that the
endocytotic nanoprobes in the tumor were further metabolized by the
reticuloendothelial system of the tumor cells.30 The MR signal values
in mice tumors treated with Fe3O4@Au-HPG-Glc nanoprobes showed
a decreasing trend before 12 h and presented a slight increase at 24 h.
This effect may be attributed to the Glc-mediated targeting effect
acting as a synergistic motivator to enhance the uptake of Fe3O4@Au-
HPG-Glc nanoprobes. The time-dependent MR signal intensities and
relative T2-signal changes (ΔT2/T2) of the tumors were quantitatively
analyzed. As shown in Figures 7b and c, the tumor signal intensity of
the control group reached a minimum value of 1331.96 at 8 h
postinjection due to the passive enhanced permeability and retention
effect. However, the tumor signal intensity of the experimental group
decreased remarkably from 1901.07 (0 h) to 1190.27 at 12 h post-
injection due to passive and active targeting. Additionally, the
distribution of the Fe3O4@Au-HPG-Glc nanoprobes in the tumors
was more uniform than that of the nontargeted NPs. As expected,
cellular internalization was improved to some extent by the special
Figure 4 TEM images of MGC-803 cells treated with Fe3O4@Au-HPG-Glc nanoprobes was observed under low power (a), intermediate magnification in the
selected area (b) and high magnification in the selected area (c). Note that the red arrows indicate the nanoprobes in cytoplasm of the MGC-803 cells, and
the yellow arrows indicate nanoprobe dispersions as secretions being excluded by the MGC-803 cells.
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targeting effect. The results indicated that the synthesized Fe3O4@Au-
HPG-Glc nanoprobes showed considerable potential as a prolonged
tumor-targeted T2 contrast agent for clinical applications.
In vivo biodistribution of Fe3O4@Au-HPG-Glc nanoprobes
To evaluate the targeting efficiency and biodistribution behavior of
Fe3O4@Au-HPG-Glc nanoprobes, the uptake of Fe and Au in the
tumors and major organs (for example, liver, kidneys and spleen) at
24 h postinjection were quantitatively analyzed using ICP–atomic
emission spectrometry and ICP–mass spectrometry, respectively. The
distribution of Fe (Figure 8a) in the tumors and major organs was
fairly consistent compared with that of Au (Figure 8b). We found that
Fe and Au were distributed in the liver (72.35 μg Fe and 71.83 ng Au
per gram liver tissue), kidneys (65.16 μg Fe and 93.55 ng Au per gram
kidney tissue) and spleen (17.11 μg Fe and 39.17 ng Au per gram
spleen tissue) at 24 h postinjection. Although a few Fe3O4@Au-HPG-
Figure 5 In vitro physical therapy. The microscope images at ×20 magnification of cells treated with Fe3O4@Au-HPG and Fe3O4@Au-HPG-Glc under
alternating magnetic field and microscope photos of cells under alternating magnetic field (experimental group), scale bar: 100 μm.
Figure 6 In vitro physical therapy. The representative microscope images at × 40 magnification of cells that had interacted with Fe3O4@Au-HPG-Glc
nanoprobes under alternating magnetic field. The cellular response to AMF stimulation mainly include stretching deformation (a), cell membrane perforation
(b, d), and cell disruption (c). Note that the red circles were labeled nanoprobes in the cells’ outer edge and inside region.
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Glc nanoprobes were detected in these tissues, there was no toxicity or
side effects in the absence of an AMF. The targeted-Fe3O4@Au-HPG-
Glc nanoprobes accumulated in the tumor site to approximately 65%,
which was significantly higher than that of the nontargeted
Fe3O4@Au-HPG nanoprobes, demonstrating the effectiveness of these
NPs for MRI-guided tumor therapy.
In vivo physical therapeutic efficacy of Fe3O4@Au-HPG-Glc NPs
To evaluate the in vivo physical therapeutic efficacy of Fe3O4@Au-
HPG-Glc nanoprobes, changes in tumor volumes were recorded using
Vernier calipers for 12 days (Figure 9a). Mice tumor sites were treated
with PBS, Fe3O4@Au-HPG nanoprobes or Fe3O4@Au-HPG-Glc
nanoprobes in the presence and absence of an AMF for 1 h after 8,
24 and 36 h postinjection, respectively. Figure 9b shows that the tumor
growth of the blank group (PBS) under an AMF was much faster than
the other experimental groups. Compared with the blank group, the
inhibition of tumor growth in mice treated with Fe3O4@Au-HPG-Glc/
AMF was up to ~ 47.3% on the twelfth day, indicating a remarkable
efficacy. The tumor growth of MGC-803-bearing mice treated with
Fe3O4@Au-HPG/AMF was ~ 25.7%. However, the inhibition of tumor
growth of mice treated with Fe3O4@Au-HPG nanoprobes in the
absence of AMF was nearly negligible and that of Fe3O4@Au-HPG-Glc
Figure 7 In vivo MRI. (a) The T2-weighted MR images of the mice bearing MGC-803 tumor before and after injection of the nontargeted Fe3O4@Au-HPG or
targeted Fe3O4@Au-HPG-Glc; (b) the signal intensity of MRI in tumor sites; (c) the relative T2-signal change (ΔT2/T2) in tumor sites before and after
injection. *Po0.05, **Po0.01.
Figure 8 In vivo biodistribution of (a) Fe and (b) Au in tumors and major organ tissue of the tumor-bearing mice 24 h after injection of the Fe3O4@Au-HPG
and Fe3O4@Au-HPG-Glc, compared with the blank group. *Po0.05, **Po0.01.
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nanoprobes without an AMF was approximately 8.9%. Additionally, as
shown in Supplementary Figure S10, at day 12, many more damaged
cells were observed in the Fe3O4@Au-HPG-Glc+AMF group and no
obvious damaged tumor cells were observed in the PBS+AMF group.
Fe3O4@Au-HPG-Glc nanoprobes stimulated by an AMF had remark-
able efficacy for MRI-guided physical therapy due to the targeted
uptake by tumor cells and tumor cell disruption. To evaluate the
potential toxicity of flower-like Fe3O4@Au-HPG-Glc nanoprobes,
variations in mice weight were measured using a visual indicator.
Figure 9d shows no evident changes in mice weight in the blank and
experimental groups. At day 12, mice were killed, and isolated organs
were embedded in paraffin and sectioned. Using hematoxylin and
eosin staining, the obtained tissue sections were examined using
microscopy. Figure 9c shows that the organ tissues of the experimental
group had no evident pathological changes or other anomalies when
compared with the blank group. Histopathological examinations after
treatment under an AMF further confirmed that the Fe3O4@Au-HPG-
Glc nanoprobes were safe and had no evident toxicity and side effects
in vivo. Considering the low retention of Fe3O4@Au-HPG-Glc nanop-
robes in the spleen, liver and kidneys after 24 h injection, no distinct
long-cycle side effects were observed after 12 days in vivo therapy.
CONCLUSIONS
In summary, we developed a novel flower-like targeting Fe3O4@Au-
HPG-Glc nanoprobe for effective MRI and enhanced gastric tumor
therapy. The nanoprobes integrated dendrimers, targeting molecules
and unique flower-like Fe3O4@Au NPs into a versatile all-in-one
nanoplatform. Under an AMF, the biodegradable flower-like
Fe3O4@Au nanoprobes can be rotated owing to axial dissymmetry.
This special behavior promoted the mechanical destruction of tumor
cells (for example, cell membrane damage, organelle damage and
nuclear damage), which could potentially reduce malignant tumor
therapy drug resistance. Simultaneously, the tumor lesion and
boundary can be precisely diagnosed using real-time MRI. Based on
MRI, the Fe3O4@Au-HPG-Glc nanoprobes were targeted to tumor
sites under an AMF. The synthesized Fe3O4@Au-HPG-Glc nanop-
robes exhibited good biocompatibility, colloidal stability, specific active
targeting and nonimmunogenicity. Only under an AMF for 15 min,
cultured MGC-803 cells were completely destroyed. Furthermore, the
inhibition of tumor growth in mice treated with Fe3O4@Au-HPG-Glc
nanoprobes can reach up to ~ 47.3% by the twelfth day. The special
flower-like structure of Fe3O4@Au-HPG-Glc nanoprobes may be used
for the repeated treatment of tumors under AMFs. These nanoprobes
are superior to traditional nanoprobes with spherical structures. The
application of flower-like structure of Fe3O4@Au-HPG-Glc nanop-
robes for the targeted therapy of gastric tumor provides a new pathway
for resolving drug resistance issues of current cancer therapies.
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